Given the frequency at which abnormalities in EGFR signaling are present in human breast cancer and observations of how these changes influence tumor cell survival, migration, metastasis, and angiogenesis, EGFR has been an attractive target for therapeutic manipulation. This evidence concerns the gene EGFR and breast cancer.